State of Art Chemoimmunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for State of Art Chemoimmunotherapy, covering 2025-05-30 to 2025-05-30. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Feasibility Study of Combination of State of Art Chemoimmunotherapy, Intensive Central Nervous System Prophylaxis and Scrotal Irradiation to Treat Primary Diffuse Large B-cell Lymphoma of Testis [Phase 2]